CodeBlue urges Malaysian MPs to vote for tobacco control bill

Jul.18.2022
CodeBlue urges Malaysian MPs to vote for tobacco control bill
Malaysian health NGO, CodeBlue, urges lawmakers to support the Tobacco and Smoking Control Bill to ban cigarettes for those born after 2005.

CodeBlue, a non-profit health organization in Malaysia, is urging lawmakers to vote in support of the "Tobacco and Smoking Control Bill," which would prohibit individuals born after 2005 from purchasing and using cigarettes. Here is the full statement.


The crucial "Tobacco and Smoking Control Act" will be submitted to Parliament this week, which will have an impact on the health and social welfare of our future generations. It is crucial that all members of Parliament fully understand these issues and support this important legislation.


It is important to note that this bill does not restrict smoking among adults, but rather aims to prohibit the sale and use of cigarettes and e-cigarette products to all children born after 2005 (those who will turn 18 in 2023).


Smoking is a rapidly growing epidemic among our children. The 2019 national health and disease rate survey provides us with national data on adolescent smoking behavior. The data is alarming for children aged 15 to 19, as it shows a significant increase in smoking rates.


At present, there are 303,800 smokers, accounting for 11.6% of the population.


A total of 196,000 individuals, which is equivalent to 7.5% of the population, are currently using e-cigarettes.


15.6% of teenagers aged 15 to 19 are currently using tobacco products.


It is anticipated that since the investigation, there has been a significant increase in the number of adolescents who have started using electronic cigarettes in recent years. As pediatricians, we are aware that many young children are drawn to using electronic cigarette products due to their appealing flavors and stylish devices, as well as the desire to appear "cool".


Teenagers smoking electronic cigarettes and becoming addicted can be seen throughout the country. It is widely recognized that most smokers develop their habit in their teens, and smoking e-cigarettes only makes it easier to develop addiction.


Worrying statistics have emerged from the Malaysian National Tobacco and E-cigarette Survey among Youth (TECMA), which shows that 9.1% of Malaysian youths aged 10 to 19 currently use e-cigarettes, with at least 600,000 children included in this group. Among these children, half started using e-cigarettes before the age of 14.


Smoking addiction is extremely difficult to overcome. Some users will gradually turn to more addictive and harmful drugs.


We urge our congressional representatives to consider the health and well-being of all of our children. Please vote in favor of the Tobacco Control Act. The impact of eliminating a major source of social ills and reducing the long-term health problems and death tolls cannot be overstated.


Voting in favor of this bill is a vote in support of investing in the current and future health and well-being of our children.


Voting in favor of the bill represents a vote of hope for all families whose children are no longer addicted to drugs or e-cigarettes.


Voting in favor of the bill is a vote in support of our healthcare system to alleviate the burden of major illnesses.


Dr. Amar-Singh HSS is a pediatric consultant.


Dr. Selva Kumar is a pediatric consultant and the president of the Malaysian Pediatric Association (MPA).


Dr. Musa Mohd Nordin, pediatric consultant.


Dr. Zulkifli Ismail, Pediatric Consultant.


Dr. Thiyagar Nadarajaw is a pediatric consultant and vice president of the Malaysian Adolescent Health Association (MAAH).


Please provide context and the original text to be translated.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
F1 Faces Renewed Pressure Over Tobacco and Nicotine Sponsorships as 67 Groups Target ZYN and VELO Ahead of Madrid Race
Ahead of the Formula 1 race in Madrid, 67 Spanish and international public-health, medical and consumer organizations have sent an open letter to F1 President and CEO Stefano Domenicali calling for an end to sponsorships linked to the tobacco and nicotine industry, including nicotine pouches, vaping products and heated tobacco. The letter focuses on Philip Morris International’s ZYN partnership with Ferrari and British American Tobacco’s long-running partnership with McLaren and exposure for VELO. The campaign follows a March letter in which more than 160 organizations worldwide made a similar request to Formula 1.
Sep.10
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives